ÂÜÀòÂÒÂ×

Nick has more than 20 years experience in muscle research. He trained as a Physiologist in Australia, completing his Ph.D. at Monash University and a Postdoctoral Fellowship at the University of Sydney. He is currently a Research Associate Professor at the University of Washington. His research findings have pioneered important new insights into the mechanisms leading to muscle weakness in Duchenne muscular dystrophy (DMD). Nick has developed novel therapies that have shown great promise in pre-clinical models of Duchenne muscular dystrophy. His innovative Non-Viral platform has the potential to provide gene therapy treatment for a wide-range of neuromuscular disorders and other muscle-related diseases.